ATRN-119, our ATR inhibitor, exhibits early evidence of single agent, anti-tumor activity and is progressing toward the recommended Phase 2 dose (RP2D) in the ongoing ABOYA-119 clinical trial Three ...

Researchers have introduced DiffSMol, a generative AI model capable of generating realistic 3D structures of small molecules ...

Pivotal Phase 3 OPERA-02 trial of palazestrant in combination with ribociclib in frontline metastatic breast cancer on track for initiation in 2025, supported by promising updated efficacy data from ...

VAV1-directed MRT-6160 program advancing toward multiple Phase 2 studies, enabled by Phase 1 SAD/MAD study data supporting broad potential application in immune-mediated diseases MRT-2359 Phase 1/2 ...

First patient dosed in DENALI Part 2a clinical trial of azenosertib in patients with Cyclin E1+ PROC. Topline data from DENALI Part 2 anticipated by year end 2026 with the potenti ...

Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that its Trials in Progress abstract has been selected for ...

India, soon to be the cardiovascular disease capital, faces rising heart attack rates, especially among women who experience ...

SIR BRADLEY WIGGINS says his children feared for his life as he spiralled into an all-consuming cocaine addiction. The Team GB hero retired from cycling in December 2016 after a glittering career.

Indigenous Nigerian food plants show promise in fighting cancer by targeting cell death and inflammation, offering support ...

Feb. 3, 2025 — Maternal vitamin D levels in the first trimester were related to both prenatal growth and pregnancy outcomes, according to a new study. Low vitamin D levels during the first ...

Twenty years after planning the Allied invasion of Normandy, Gen. Dwight D. Eisenhower received a letter that asked him how the June 6, 1944, amphibious assault came to be commonly called D-Day.